This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., Commissioner of Food and Drugs

Event Date: 01/17/2024
Location: Silver Spring, MD
Subject: Rare Disease Drug Development
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: David Meeker (Rhythm Pharmaceuticals); Adora Ndu, Charles Homcy, Neil Kumar (BridgeBio Pharma); Eric Dube (Travere Therapeutics); Charlene Son Rigby (Global Genes); Jonathan Fox (Eidos Therapeutics); Ted Love (Global Blood Therapeutics); Guarav Shah (Rocket Pharmaceuticals);

Event Date: 01/19/2024
Location: Virtual
Subject: CardioMet 2024; Speaker: Role of FDA in Combatting the Public Health Threat of Cardiometabolic Disease
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other invited guests

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 01/16/2024
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members and staff from the National Association of State Departments of Agriculture

Event Date: 01/18/2024
Location: Marco Island, FL
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Food Industry Association members from across the food industry, including producers, suppliers, and retailers

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 01/19/2024
Location: Virtual
Subject: Evaluation of the World Health Organization (WHO) Member State Mechanism on Substandard and Falsified Medicines
FDA Participant/Group: N/A
Non FDA Participant/Group: Elisabetta Pegurri, Scott Matafwali (World Health Organization (WHO));

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 01/16/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: ERIN O'QUINN;
Non FDA Participant/Group: Representative Lauren Underwood (D-IL); Rita Kuwahara (Congressional Fellow)

Event Date: 01/16/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representative Cathy McMorris Rodgers (R-WA); Abigail Carroll, Grace Graham (Energy and Commerce (E&C) Majority Staff)

Event Date: 01/18/2024
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: ERIN O'QUINN;
Non FDA Participant/Group: Representative Brett Guthrie (R-KY); Brian Fahey (Congressional staff)

Event Date: 01/18/2024
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: ERIN O'QUINN;
Non FDA Participant/Group: Representative Kim Shrier (D-WA)

Event Date: 01/18/2024
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representative Ami Bera (D-CA)

Event Date: 01/18/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: PETER REIKES;
Non FDA Participant/Group: Carl Gordon, Savannah Loomis (OrbiMed Advisors LLC);

Event Date: 01/19/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: David Stacy (Human Rights Campaign);

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/18/2024
Location: Virtual
Subject: United States Pharmacopeia (USP) FY24 Plans and Mutual Cooperation with FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Ronald Piervincenzi (United States Pharmacopeia);

Event Date: 01/19/2024
Location: Virtual
Subject: Feedback on Mutual Cooperation
FDA Participant/Group: N/A
Non FDA Participant/Group: Klaus Romero (Critical Path Institute (C-PATH));

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/18/2024
Location: Fort Myers, FL
Subject: 2024 Parent Project Muscular Dystrophy Duchenne Healthcare Professionals Summit; Breaking Through the Barriers to Advance Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 2024 Parent Project Muscular Dystrophy Duchenne Healthcare Professionals Summit

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 01/16/2024
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: BARBARA CASSENS; JAMES GORNY; ERIK METTLER; MARK MOORMAN; SUZANNE ROOSEN; MICHAEL DUTCHER; DONALD PRATER; CATHERINE MCDERMOTT; JEFFREY FARRAR; JAMES JONES; MICHAEL ROGERS;
Non FDA Participant/Group: Representatives of the National Association of State Departments of Agriculture (NASDA)

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event